- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: azd0530.
Displaying page 1 of 1.
EudraCT Number: 2007-005325-30 | Sponsor Protocol Number: D8180C00015 | Start Date*: 2008-04-25 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase II, Double-Blind, Placebo Controlled, Multi-Centre, Randomised Study of AZD0530 in Patients with Advanced Ovarian Cancer Sensitive to Platinum-Based Chemotherapy | |||||||||||||
Medical condition: advanced ovarian cancer sensitive to platinum based chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) FR (Completed) DK (Completed) PT (Completed) BG (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005999-13 | Sponsor Protocol Number: D8180C00034 | Start Date*: 2008-02-21 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Phase II, Randomised, Open-label, Pilot Study to Evaluate the Safety and the Effects on Bone Resorption of AZD0530 in Patients with Prostate Cancer or Breast Cancer with Metastatic Bone Disease ... | ||
Medical condition: Prostate Cancer or Breast Cancer with Metastatic Bone Disease Cáncer de próstata o de mama con metástasis óseas | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) GB (Completed) SE (Completed) PT (Completed) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-003324-20 | Sponsor Protocol Number: STOPFOP1 | Start Date*: 2020-01-08 | |||||||||||
Sponsor Name:VU University Medical Center | |||||||||||||
Full Title: Saracatinib trial TO Prevent FOP | |||||||||||||
Medical condition: Fibrodyplasia Ossificans Progressiva (FOP) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021447-41 | Sponsor Protocol Number: SAPROCAN2011 | Start Date*: 2011-05-12 | |||||||||||
Sponsor Name:NHS Greater Glasgow Health Board [...] | |||||||||||||
Full Title: SAPROCAN: Saracatinib (AZD0530) and docetaxel in metastatic, castrate-refractory prostate cancer: a phase I/randomised phase II study by the UK NCRI Prostate Clinical Studies Group | |||||||||||||
Medical condition: Metastatic, castration-resistant prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017171-13 | Sponsor Protocol Number: UCL/09/0105 | Start Date*: 2010-08-23 | ||||||||||||||||
Sponsor Name:University College London | ||||||||||||||||||
Full Title: A randomised placebo-controlled trial of saracatinib (AZD0530) plus weekly paclitaxel in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer. | ||||||||||||||||||
Medical condition: Platinum-resistant ovarian, fallopian tube or primary peritoneal cancer. The relevant MedDRA codes for recurrent ovarian cancer and fallopian tube cancer are given below. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-002157-64 | Sponsor Protocol Number: | Start Date*: 2012-03-07 |
Sponsor Name:Common Services Agency | ||
Full Title: ARomatase Inhibition plus minus SaracaTinib as Advanced breast CAncer Therapy: a randomised phase II study of aromatase inhibition plus/minus the src-inhibitor AZD0530 in post-menopausal women with... | ||
Medical condition: Advanced breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002505-62 | Sponsor Protocol Number: STH16404 | Start Date*: 2013-11-14 | |||||||||||
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | |||||||||||||
Full Title: SarCaBon: A randomised phase II trial of Saracatinib versus placebo for cancer-induced bone pain | |||||||||||||
Medical condition: Cancer-induced bone pain | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-018014-20 | Sponsor Protocol Number: COSAKV1 | Start Date*: 2010-04-19 |
Sponsor Name:Common Services Agency | ||
Full Title: A Randomised Phase II Study Evaluating Cediranib vs. Cediranib and Saracatanib in patients with relapsed metastatic clear cell renal cancer | ||
Medical condition: Clear Cell Renal Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.